A proven strategy to accelerate drug approvals
Companion Diagnostics represents a critical milestone in precision medicine and plays a pivotal role in the validation of targeted therapies. Traditional CDx development models involve multiple partners adding complexity and increasing risk which could affect drug approvals. Our Streamlined CDx® program has demonstrated value, accelerating the international approvals of multiple new targeted therapies for multiple pharmaceutical companies.
A proven strategy to accelerate drug approvals
Companion Diagnostics represents a critical milestone in precision medicine and plays a pivotal role in the validation of targeted therapies. Traditional CDx development models involve multiple partners adding complexity and increasing risk which could affect drug approvals. Our Streamlined CDx™ program has demonstrated value, accelerating the international approvals of multiple new targeted therapies for multiple pharmaceutical companies.
Product Development
Product Development
Manufacturing
Manufacturing
LabPMM®
LabPMM®
Global Regulatory Expertise
Global Regulatory Expertise
PARTNERSHIPS
Related Articles
PARTNERSHIPS
Related Articles